Vice President, Assay Development – Stellaromics Inc. – Jobs in Boston, MA | OpenJobs AI

Job Details

Overview Company

Vice President, Assay Development

$220k/y-$270k/y

Stellaromics Inc.

3 days ago

Highlight

OnsiteFull-timeExecutive

Summary

Stellaromics Inc. is seeking a Vice President, Assay Development to join their team in Boston, MA. The role involves owning the end-to-end performance and long-term vision for assays, requiring deep molecular biology expertise and exceptional leadership skills.

About the Role

As the Vice President of Assay Development, you will define and execute a 3-5 year technical vision and product roadmap for the Pyxa/STARmap assay portfolio. You will lead efforts to improve data quality and robustness, direct assay design and optimization, provide technical oversight, and manage a high-performing team while collaborating across functions to ensure successful product delivery.

About You

Required:

Ph.D. in Molecular Biology, Genomics, Bioengineering, or a related field.
Minimum of 10+ years of progressive experience in assay development within the biotechnology, diagnostics, or life sciences tool industry, with at least 5 years in a senior leadership/management role.
Deep technical understanding of complex genomics assays and direct experience with spatial transcriptomics or multiplexed imaging platforms.
Proven success in taking novel molecular assays from late-stage R&D through Verification, Validation, and Commercial Launch.
Demonstrated ability to be a strong leader and a collaborative team player.

Preferred:

Experience with thick tissue processing or advanced tissue staining protocols.
Familiarity with regulatory requirements (e.g., CLIA/CAP, ISO 13485).

Benefits

Innovative technology at the cutting edge of spatial biology and genomics.
Significant impact on the department and future of the company.
Collaborative environment with a talented team.
Opportunities for professional development and career advancement.
Attractive compensation and benefits package.

Stellaromics Inc.

Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations. Stellaromics is currently in the advanced stages of developing its Pyxa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases. For comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.

Boston, MA